Industry

Bruxelles Woluwe

Stallergènes

(2013 – 2016)
Marc DILLEMBOURG, Olga Maria CRUZ-MITJANS, Dennys CRUZ-MITJANS, Jean-François DURANT

The project aims at producing freeze dried, gamma inactivated, fungal raw material for use in allergy research & treatment, starting from pure cultures & inert substrates.

A service type contract has recently been signed with a biopharmaceutical industry leader specialized in the treatment of severe respiratory allergies.

Consequently, selected strains have been deposited at Mycothèque de l’Université catholique de Louvain (BCCM/MUCL).

The production of biomasses can be adjusted to the specificities of any customer (scientific community or industrial sector) in order to guarantee the quality of allergen extracts made using our products.

UCL-CTMA/MYCO meets strict quality & safety standards, in compliance with European regulatory requirements (origin, processing, identification & purity).

It has the equipment & expertise allowing detection, identification & monitoring of microbial contaminants of indoor & outdoor air. Detection & monitoring is based on surface & air sampling methods. Identification of airborne particles is achieved by standard light microscopy, culture, SDS-PAGE profiling & DNA signature sequences.

Another goal of the project is to perform research on the quantification and analysis of proteins for test and control purposes and in the context of allergy test.

 

fig16

Conidia of Alternaria alternata
(standard light microscopy, x 400)